Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphomaF Morschhauser, C Recher, N Milpied, et al.
Bone Marrow Transplantation|June 11, 2013
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCTJ El-Cheikh, G Venton, R Crocchiolo, et al.
Annals of Hematology|February 24, 2020
Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcomeB Bouchacourt, M A Hospital, C Zemmour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S O'Brien, et al.
Leukemia|April 16, 2011
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemiasR Itzykson, O Kosmider, T Cluzeau, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 24, 2013
Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patientsG Venton, R Crocchiolo, S Fürst, et al.
Bone Marrow Transplantation|September 10, 2005
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantationV Ivanov, C Faucher, M Mohty, et al.
Bone Marrow Transplantation|July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsC Faucher, A G Le Corroller Soriano, B Esterni, et al.
Leukemia Research|August 2, 2011
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDSS Park, R Sapena, C Kelaidi, et al.
Pageof 7